These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 155391)

  • 21. Comparison of the opacifying characteristics and pharmacologic responses of iocetamic acid (Cholebrine), a new oral cholecystographic agent, with sodium tyropanoate (Bilopaque).
    Wishart DL; Dotter CT
    Am J Roentgenol Radium Ther Nucl Med; 1973 Oct; 119(2):429-32. PubMed ID: 4748234
    [No Abstract]   [Full Text] [Related]  

  • 22. Subjective vs. objective evaluation of gallbladder opacification during oral cholecystography in comparative clinical trials: implications for studies involving visual assessment.
    Fon GT; Hunter TB; Berk RN; Patton DD; Capp MP
    Radiology; 1982 Jul; 144(2):277-80. PubMed ID: 7089280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal toxicity following oral cholecystography with oragrafin (ipodate calcium).
    Harrow BR; Winslow OP
    Radiology; 1966 Oct; 87(4):721-4. PubMed ID: 5923766
    [No Abstract]   [Full Text] [Related]  

  • 24. [Initial experience with the Soviet preparation, biloptin, for oral cholecystocholangiography].
    Popova ZP; Ushakov VL; Sviridov NK
    Vestn Rentgenol Radiol; 1979; (2):23-7. PubMed ID: 375563
    [No Abstract]   [Full Text] [Related]  

  • 25. Single-visit oral cholecystography for inpatients.
    Burhenne HJ; Morris DC; Graeb DA
    Radiology; 1981 Aug; 140(2):505-6. PubMed ID: 7255728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oragrafin, a new cholecystographic medium: a double-blind comparison with Telepaque.
    JUHL JH; COOPERMAN LR; CRUMMY AB
    Radiology; 1963 Jan; 80():87-91. PubMed ID: 13957983
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative study with a closed sequential design between iopronic and iocetamic acid in oral cholecystocholangiography with radiograms in short and standard times. Laboratory evaluation of hepatic function (author's transl)].
    Lutman M; Morassut S; Bigai M; Galassi G; Galofaro G; Piazza P
    Radiol Med; 1980; 66(7-8):517-22. PubMed ID: 6452657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gallbladder density and iodine concentration in humans during oral cholecystography. A comparison of iopanoic acid and iopronic acid.
    Thompson WM; Meyers WC; Shaw M; Bates M; Johnson GA; Hedlund LW
    Invest Radiol; 1982; 17(6):621-8. PubMed ID: 6759456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double blind clinical comparison of two oral cholecystographic contrast media.
    Perez CA; Friedenberg MJ
    Mo Med; 1966 Jan; 63(1):46-9. PubMed ID: 5329730
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of oral cholecystography agents in the treatment of hyperthyroidism of subacute thyroiditis.
    Martinez DS; Chopra IJ
    Panminerva Med; 2003 Mar; 45(1):53-7. PubMed ID: 12682620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time of optimal gallbladder opacification with bilopaque (tyropanoate sodium).
    Oliphant M; Whalen JP; Evans JA
    Radiology; 1974 Sep; 112(3):531-2. PubMed ID: 4843281
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical comparison of locetamic acid, lopanoic acid and tyropanoate sodium.
    Marshall TR
    J Indiana State Med Assoc; 1976 Oct; 69(10):742-3. PubMed ID: 135811
    [No Abstract]   [Full Text] [Related]  

  • 33. Determinants of the rate of intestinal absorption of oral cholecystographic contrast agents in the dog jejunum.
    Janes JO; Dietschy JM; Berk RN; Loeb PM; Barnhart JL
    Gastroenterology; 1979 May; 76(5 Pt 1):970-7. PubMed ID: 155546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and chemical aspects of residual contrast media in the intestine during oral cholecystography with Trijobil and Falignost].
    Quasdorf M; Becker C; Quasdorf G; Becker HW
    Radiol Diagn (Berl); 1977; 18(1):19-28. PubMed ID: 866607
    [No Abstract]   [Full Text] [Related]  

  • 35. [A method for the investigation of cholegraphic contrast media. Experiments using isolated perfused rat livers (author's transl)].
    Otto H
    Rofo; 1982 May; 136(5):546-53. PubMed ID: 6212501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of calcium Oragrafin granules in repeat cholecystography, with supplemental ultrasonographic evaluation.
    Fiske SA; Stamper DW
    J Am Osteopath Assoc; 1984 Mar; 83(7):512-5. PubMed ID: 6706718
    [No Abstract]   [Full Text] [Related]  

  • 37. [Trial of Bilopaque, a new contrast medium for oral cholecystography].
    Magos E; Delhaye J; Dejong M
    J Belge Radiol; 1976; 59(4):369-76. PubMed ID: 795805
    [No Abstract]   [Full Text] [Related]  

  • 38. Gall-bladder contraction and bile duct opacification in oral cholecystography--a comparison of different methods.
    McConnell CA; Whitehouse GH; Evans AF
    Br J Radiol; 1983 Jun; 56(666):371-6. PubMed ID: 6342701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The use of bilimin in the radiologic study of the gallbladder].
    Kanishchev PA; Sokolov AL
    Vrach Delo; 1989 May; (5):68-9. PubMed ID: 2773441
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacologic properties of a new oral contrast medium for cholecystography.
    Rosati G; De Micheli P; Schiantarelli P
    Acta Radiol Diagn (Stockh); 1972 May; 12(3):335-46. PubMed ID: 5045427
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.